Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dezocine |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing butorphanol (medicinal product) |
Is a |
True |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing buprenorphine (medicinal product) |
Is a |
True |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing pentazocine (medicinal product) |
Is a |
True |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing nalbuphine (medicinal product) |
Is a |
True |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing dezocine (medicinal product) |
Is a |
True |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Pentazocine hydrochloride 25 mg oral tablet |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
nalbufinhydroklorid 20 mg/2 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
pentazocin (som pentazocinlaktat) 30 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|
pentazocin (som pentazocinlaktat) 60 mg/2 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing opioid receptor partial agonist (product) |
Inferred relationship |
Some |
|